GPR55 is a non-CB1/CB2 receptor that exhibits affinity for endogenous, plant and synthetic cannabinoids. Originally designated an orphan receptor, GPR55 is now thought to be a functional receptor mediating the effects of ligands known to be inactive at CB1 and CB2, e.g. palmitoylethanolamide. GPR55 couples to Gα13 and can mediate activation of the small G proteins rhoA, cdc42 and rac1.
GPR55 mRNA is expressed in the brain, most abundantly in the caudate nucleus and putamen, with lesser levels in the hippocampus, thalamus, pons, cerebellum and frontal cortex. Peripherally, GPR55 mRNA is present in the spleen, adrenals and parts of the gastrointestinal tract. Putative physiological roles of GPR55 include pain signaling, control of vascular tone and inflammation. The human GPR55 receptor gene is localized to chromosome 2q36.3.
To view external sources of pharmacological information for GPR55, please click here: IUPHAR Receptor CodeView all products for GPR55 »
|Species||Gene Symbol||Gene Accession No.||Protein Accession No.|
Literature for GPR55
A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:
- Rhodopsin-like Receptors
- Secretin-like Receptors
- Glutamate Receptors
- Frizzled Receptors
- GPCR Signaling
A collection of over 250 products for pain research, the guide includes research tools for the study of:
- Ion Channels
- G-Protein-Coupled Receptors
- Intracellular Signaling
Written by Roger Pertwee, this review discusses compounds which affect the activity of the endocannabinoid system, focusing particularly on ligands that are most widely used as experimental tools and denotes compounds available from Tocris.Request copy | Download PDF | View all reviews